| 摘要 |
<p>NOVEL COMBINED VACCINE COMPOSITIONS ARE PROVIDED, COMPRISING A HEPATITIS B VIRAL ANTIGEN AND A HPV ANTIGEN AND OPTIONALLY IN ADDITION ONE OR MORE OF THE FOLLOWING: AN EBV ANTIGEN, A HEPATITIS A ANTIGEN OR INACTIVATED ATTENUATED VIRUS, A HERPES SIMPLEX VIRAL ANTIGEN, A VZV ANTIGEN, A HCMV ANTIGEN, A TOXOPLASMA GONDII ANTIGEN. THE VACCINE COMPOSITIONS ARE FORMULATED WITH AN ADJUVANT WHICH IS A PREFERENTIAL STIMULATOR OF THI CELL RESPONSE SUCH AS 3D-MPL AND QS21.</p> |
